Amgen opens new technology and innovation site in Hyderabad
Amgen India investment totals $200 million through 2025
Amgen India investment totals $200 million through 2025
Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
The acquisition aligns with Granules' vision to enter the rapidly expanding peptide-based anti-diabetic and anti-obesity market
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
The company anticipates 2025 worldwide sales to be between $64.1 billion and $65.6 billion
The company is committed to revolutionizing API development by advancing synthesis and analytical processes that enhance quality and impact lives
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
The combined entity will leverage its complementary strengths to deliver unparalleled solutions in protein purification and stabilization
Subscribe To Our Newsletter & Stay Updated